Filing metadata

Accession number
0001654954-22-001625
Form type
Form 3
Filer
GT Biopharma, Inc.
CIK
CIK 109657
Filed
Feb 14, 2022
Reporting period
Jan 13, 2021
Description
Initial ownership

Explore SEC Filings Hub